These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 215108)

  • 21. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
    Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H
    Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encephalomyocarditis (EMC) virus-induced diabetes mellitus prevented by Corynebacterium parvum in mice.
    Kounoue E; Nagafuchi S; Nakamura M; Nakano S; Koga T; Nakayama M; Mituyama M; Niho Y; Takaki R
    Experientia; 1987 Apr; 43(4):430-1. PubMed ID: 3032672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenicity of neutral red.
    Longnecker DS; Curphey TJ; Daniel DS
    Mutat Res; 1977; 48(1):109-11. PubMed ID: 319350
    [No Abstract]   [Full Text] [Related]  

  • 24. Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line.
    Khabar KS; Al-Zoghaibi F; Murayama T; Matsushima K; Mukaida N; Siddiqui Y; Dhalla M; Al-Ahdal MN
    Biochem Biophys Res Commun; 1997 Jun; 235(3):774-8. PubMed ID: 9207237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of free immunoglobulin light chains on viral myocarditis.
    Matsumori A; Shimada M; Jie X; Higuchi H; Groot Kormelink T; Redegeld FA
    Circ Res; 2010 May; 106(9):1533-40. PubMed ID: 20360247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ENCEPHALOMYOCARDITIS (EMC) VIRUSES. ANTIBODY DETERMINATIONS ON HEALTHY SUBJECTS IN THE HALLE AREA].
    KOEHLER W; SCHMIDT RM
    Z Arztl Fortbild (Jena); 1963 Sep; 57():983-6. PubMed ID: 14091776
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of infectivity of encephalomyocarditis virus RNA by amphotericin B methyl ester.
    Borden EC; Booth BW; McBain JA
    J Gen Virol; 1979 Feb; 42(2):297-303. PubMed ID: 217959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of T cells, B cells, antibodies and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice.
    Kounoue E; Izumi K; Ogawa S; Kondo S; Katsuta H; Akashi T; Niho Y; Harada M; Tamiya S; Kurisaki H; Nagafuchi S
    Arch Virol; 2008; 153(7):1223-31. PubMed ID: 18500429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells.
    Kaptur PE; Thomas DC; Giron DJ
    Diabetes; 1989 Sep; 38(9):1103-8. PubMed ID: 2475377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
    Jordan GW; Cohen SH
    Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses to two encephalomyocarditis virus vaccines in rhesus macaques (Macaca mulatta).
    Emerson CL; Wagner JL
    J Med Primatol; 1996 Jan; 25(1):42-5. PubMed ID: 8740951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different pH requirements for entry of the two picornaviruses, human rhinovirus 2 and murine encephalomyocarditis virus.
    Madshus IH; Olsnes S; Sandvig K
    Virology; 1984 Dec; 139(2):346-57. PubMed ID: 6097029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encephalomyocarditis (EMC) virus-induced sialodacryoadenitis in mice.
    Ohguchi A; Nakayama Y; Doi C; Nakayama H; Doi K
    Exp Mol Pathol; 2005 Feb; 78(1):58-63. PubMed ID: 15596062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice.
    Yoon J; Onodera T; Notkins AL
    J Gen Virol; 1977 Nov; 37(2):225-32. PubMed ID: 200705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Permissiveness of mouse, monkey and hybrid cells to encephalomyocarditis (EMC) virus.
    Dubois MF; Chany C
    J Gen Virol; 1976 May; 31(2):173-81. PubMed ID: 180239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacological relevance of vital staining with neutral red.
    Nemes Z; Dietz R; Lüth JB; Gomba S; Hackenthal E; Gross F
    Experientia; 1979 Nov; 35(11):1475-6. PubMed ID: 510488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stimulation of mouse encephalomyocarditis virus reproduction by non-multiplying poliomyelitis virus in several transplantable tissue culture lines].
    Maslova SV; Shirman GA; Gavrilovskaia IN
    Vopr Virusol; 1977; (6):733-9. PubMed ID: 203116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.
    Czarniecki CW; Allen PT
    Antiviral Res; 1984 Dec; 4(6):351-5. PubMed ID: 6099710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of hyperthermia on experimental viral infections in vitro.
    Panasiak W; Oraczewska A; Luczak M
    Adv Exp Med Biol; 1990; 267():471-5. PubMed ID: 1965095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.